Clotting Factor Synthesis and Liver Function Tests in Frail Patients

Understanding the Relationship

The liver synthesizes most clotting factors and other proteins like albumin that are measured in standard liver function tests, and when hepatic synthetic function declines, there is a parallel reduction in both clotting factor production and other liver-derived proteins, as noted by the Journal of Thrombosis and Haemostasis 2, 3

Decreased synthesis of liver-derived procoagulant factors causes prolongation of prothrombin time, which correlates with disease severity, according to the American Association for the Study of Liver Diseases 1, 4
Decreased synthesis of anticoagulant factors occurs simultaneously, creating a "rebalanced" but fragile hemostatic state, as reported by the Journal of Thrombosis and Haemostasis 3, 1, 4
The severity of coagulation abnormalities typically correlates with overall liver disease severity, meaning other liver function test abnormalities will be present, as stated by the American College of Gastroenterology 4

Factor VIII levels are often elevated or normal in cirrhosis because it is not produced by hepatocytes, as noted by the European Association for the Study of the Liver 1, 4
Von Willebrand factor is consistently elevated in cirrhosis, which partially compensates for thrombocytopenia and other coagulation defects, according to the International Society on Thrombosis and Haemostasis 1, 4

Assess disease severity using Child-Pugh or MELD scoring, as coagulation abnormalities parallel overall hepatic dysfunction, as recommended by the American Association for the Study of Liver Diseases 4
Recognize that standard coagulation tests are inadequate for assessing bleeding risk in liver disease because they only measure procoagulant deficiencies and ignore compensatory mechanisms, as stated by the American College of Chest Physicians 1, 4

Do not use PT/INR alone to predict bleeding risk in patients with liver disease, as the hemostatic system is rebalanced and bleeding risk is largely attributable to portal hypertension rather than coagulopathy per se, as noted by the European Association for the Study of the Liver 1, 4
In frail patients with critical illness, sepsis, or renal failure, the coagulation profile may be more severely affected and may not correlate as predictably with other liver function tests, as reported by the Society of Critical Care Medicine 2, 4